Compare Lupin Ltd with IPCA Labs - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN vs IPCA LABS - Comparison Results

LUPIN     Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

IPCA LABS 
   Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LUPIN IPCA LABS LUPIN/
IPCA LABS
 
P/E (TTM) x 47.5 22.9 206.9% View Chart
P/BV x 2.4 4.4 54.7% View Chart
Dividend Yield % 0.0 0.1 -  

Financials

 LUPIN   IPCA LABS
EQUITY SHARE DATA
    LUPIN
Mar-19
IPCA LABS
Mar-18
LUPIN/
IPCA LABS
5-Yr Chart
Click to enlarge
High Rs986695 141.8%   
Low Rs720400 180.1%   
Sales per share (Unadj.) Rs369.5260.2 142.0%  
Earnings per share (Unadj.) Rs13.419.0 70.7%  
Cash flow per share (Unadj.) Rs37.433.1 113.1%  
Dividends per share (Unadj.) Rs01.00 0.0%  
Dividend yield (eoy) %00.2 0.0%  
Book value per share (Unadj.) Rs303.7213.0 142.6%  
Shares outstanding (eoy) m452.49126.20 358.5%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.32.1 109.7%   
Avg P/E ratio x63.628.9 220.5%  
P/CF ratio (eoy) x22.816.6 137.7%  
Price / Book Value ratio x2.82.6 109.3%  
Dividend payout %05.3 0.0%   
Avg Mkt Cap Rs m386,06469,120 558.5%   
No. of employees `00017.713.3 133.4%   
Total wages/salary Rs m31,5137,359 428.2%   
Avg. sales/employee Rs Th9,453.82,477.4 381.6%   
Avg. wages/employee Rs Th1,782.0555.2 321.0%   
Avg. net profit/employee Rs Th343.0180.6 189.9%   
INCOME DATA
Net Sales Rs m167,18232,836 509.1%  
Other income Rs m3,640418 870.9%   
Total revenues Rs m170,82233,254 513.7%   
Gross profit Rs m28,8224,505 639.8%  
Depreciation Rs m10,8501,777 610.5%   
Interest Rs m3,078240 1,281.6%   
Profit before tax Rs m18,5342,905 637.9%   
Minority Interest Rs m-890-   
Prior Period Items Rs m380-   
Extraordinary Inc (Exp) Rs m-3,4000-   
Tax Rs m9,017511 1,764.2%   
Profit after tax Rs m6,0662,394 253.3%  
Gross profit margin %17.213.7 125.7%  
Effective tax rate %48.717.6 276.5%   
Net profit margin %3.67.3 49.8%  
BALANCE SHEET DATA
Current assets Rs m138,53619,455 712.1%   
Current liabilities Rs m61,29910,076 608.4%   
Net working cap to sales %46.228.6 161.7%  
Current ratio x2.31.9 117.0%  
Inventory Days Days8498 85.6%  
Debtors Days Days11267 167.9%  
Net fixed assets Rs m127,51620,260 629.4%   
Share capital Rs m905252 358.6%   
"Free" reserves Rs m136,51726,633 512.6%   
Net worth Rs m137,42226,886 511.1%   
Long term debt Rs m66,4172,340 2,838.2%   
Total assets Rs m279,49441,173 678.8%  
Interest coverage x7.013.1 53.6%   
Debt to equity ratio x0.50.1 555.3%  
Sales to assets ratio x0.60.8 75.0%   
Return on assets %3.36.4 51.1%  
Return on equity %4.48.9 49.6%  
Return on capital %8.910.8 82.8%  
Exports to sales %047.6 0.0%   
Imports to sales %014.9 0.0%   
Exports (fob) Rs mNA15,642 0.0%   
Imports (cif) Rs mNA4,884 0.0%   
Fx inflow Rs m59,41415,642 379.8%   
Fx outflow Rs m22,2824,884 456.3%   
Net fx Rs m37,13210,759 345.1%   
CASH FLOW
From Operations Rs m16,6603,411 488.4%  
From Investments Rs m-32,825-1,354 2,424.3%  
From Financial Activity Rs m7,441-1,304 -570.6%  
Net Cashflow Rs m-8,724753 -1,158.2%  

Share Holding

Indian Promoters % 46.6 45.9 101.5%  
Foreign collaborators % 0.2 0.0 -  
Indian inst/Mut Fund % 11.3 11.4 99.1%  
FIIs % 31.9 25.3 126.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.1 17.4 58.0%  
Shareholders   98,259 36,892 266.3%  
Pledged promoter(s) holding % 0.0 2.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LUPIN With:   FDC LTD.  UNICHEM LAB  DR. REDDYS LAB  AJANTA PHARMA  ALEMBIC LTD  

Compare LUPIN With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Stock Markets Remain in Green This Week: Is the Rebound Here?(Podcast)

After a long period of underperformance, stock markets traded in green territory throughout the week. So, is this is a trend reversal and is the bottom forming in the market?

Related Views on News

IPCA LABS Announces Quarterly Results (1QFY20); Net Profit Up 101.5% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, IPCA LABS has posted a net profit of Rs 1 bn (up 101.5% YoY). Sales on the other hand came in at Rs 10 bn (up 18.4% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

LUPIN Announces Quarterly Results (1QFY20); Net Profit Up 49.3% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, LUPIN has posted a net profit of Rs 3 bn (up 49.3% YoY). Sales on the other hand came in at Rs 44 bn (up 14.6% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of LUPIN for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of LUPIN. Also includes updates on the valuation of LUPIN.

IPCA LABS Announces Quarterly Results (4QFY19); Net Profit Up 113.4% (Quarterly Result Update)

Jun 3, 2019 | Updated on Jun 3, 2019

For the quarter ended March 2019, IPCA LABS has posted a net profit of Rs 1 bn (up 113.4% YoY). Sales on the other hand came in at Rs 8 bn (up 6.5% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

LUPIN Announces Quarterly Results (4QFY19); Net Profit Down 1.5% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, LUPIN has posted a net profit of Rs 3 bn (down 1.5% YoY). Sales on the other hand came in at Rs 44 bn (up 77.8% YoY). Read on for a complete analysis of LUPIN's quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

Two Stocks to Buy in the Great Indian Festival(Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

LUPIN SHARE PRICE


Oct 18, 2019 (Close)

TRACK LUPIN

COMPARE LUPIN WITH

MARKET STATS